Abstract
Glioblastoma (GBM) is the most frequent and aggressive primary malignant tumor that affects the Central Nervous System (CNS) in adults. Currently, treatment consists of surgical removal of the tumor, radiotherapy and chemotherapy, and yet the median survival of patients after diagnosis is around 15 months. Recent advances in cell therapies have increased the success in the treatment of ge…